Salt Therapy and Respiratory Health

How inhaling dry salt aerosol in salt caves or halogenerator rooms supports respiratory function, reduces airway inflammation, and clears mucus

Halotherapy — breathing fine dry salt particles in a specially designed room — is a modern adaptation of an old Eastern European folk medicine practice rooted in the observation that salt miners rarely suffered from respiratory disease. Today it is practiced in dedicated salt caves and rooms equipped with halogenerators that grind pharmaceutical-grade sodium chloride into microscopic particles small enough to reach deep into the airways. Clinical reviews of the evidence find consistent improvements in lung function measures and quality of life for people with asthma, chronic bronchitis, sinusitis, and bronchiectasis [1][2]. The evidence is strongest for asthma and weakest for COPD, where only limited controlled studies exist [4]. It is considered safe, well tolerated, and complementary to — not a replacement for — standard medical care [5].

How Salt Particles Work in the Airways

When dry sodium chloride aerosol particles (1–5 micrometers in diameter) are inhaled, they penetrate from the upper airways all the way into the smaller bronchioles and even alveoli. Once there, they exert several effects that address the core problems in many chronic respiratory conditions [1][5].

Mucociliary clearance: Salt draws water into the mucus layer by osmosis, thinning thickened secretions and making it easier for cilia — the tiny hair-like structures lining the airways — to move mucus toward the throat where it can be expelled. This is particularly useful in conditions like chronic bronchitis, bronchiectasis, and sinusitis, where excessive or sticky mucus is a primary complaint.

Anti-inflammatory action: Sodium chloride at the airway surface modulates local immune responses, reducing the concentration of inflammatory cells and cytokines. Studies measuring fractional exhaled nitric oxide (FeNO) — a marker of eosinophilic airway inflammation — show reductions following halotherapy in some asthmatic patients [3].

Antibacterial effects: Hypertonic salt environments are inhospitable to many respiratory pathogens. Salt therapy reduces bacterial load on airway surfaces, which may explain some of its benefit in recurrent respiratory infections and sinusitis [5].

IgE reduction: A subset of studies report decreased immunoglobulin E (IgE) levels following halotherapy courses, suggesting a possible effect on allergic sensitization, though this finding is not universal across trials [5].

What Conditions Have Evidence

The breadth of evidence varies considerably by condition [1][2]:

Asthma: The most studied indication. Both adult and pediatric studies show improvements in bronchial hyper-responsiveness, symptom scores, and quality of life. A 2021 comprehensive review of 18 studies concluded halotherapy "proved its benefits in asthma diagnosis, treatment, and prevention" [2].
Chronic bronchitis and sinusitis: Multiple case series and controlled studies show symptom improvement and reduced medication use [1].
Bronchiectasis: Positive findings for mucus clearance and quality of life.
COPD: Evidence is the least mature — a 2014 systematic review found only four qualifying studies, and the authors could not make clinical recommendations due to study quality limitations [4].
Allergic rhinitis: Some studies show benefit, consistent with the anti-inflammatory and IgE-lowering mechanisms.

Practical Details

What a session looks like: A typical halotherapy session lasts 45–60 minutes in a room kept at 18–24°C with 40–60% relative humidity. A halogenerator disperses crushed pharmaceutical-grade NaCl at concentrations of roughly 0.5–9 mg/m³. Many commercial salt rooms also use Himalayan salt panels for aesthetic purposes, though the therapeutic benefit comes from the aerosolized particles, not the walls.

Course length: Most positive studies used 10–25 sessions conducted over several weeks. A 2017 pediatric RCT used 7 weeks of sessions with significant improvement in airway hyper-responsiveness by the end of the course [3].

Safety: Halotherapy has a very clean safety profile across clinical literature. It is generally not recommended for people with active tuberculosis, severe uncontrolled hypertension, cardiac insufficiency, or acute fever. People with cystic fibrosis should consult a specialist before use, as salt inhalation protocols for CF differ substantially from general halotherapy [1].

Home options: Personal halogenerators and saline inhalation devices designed for home use are commercially available, but the evidence base is largely drawn from professional salt room settings. Saline nasal rinses (neti pots, nasal irrigation) work through a related but distinct mechanism and have their own robust evidence base for sinusitis.

See our sauna page for another heat-based therapeutic environment with complementary respiratory and cardiovascular benefits.

Evidence Review

Systematic Review of Chronic Respiratory Conditions (Barber et al., 2022)

This review in Alternative Therapies in Health and Medicine synthesized 13 peer-reviewed articles on halotherapy for chronic respiratory conditions published between 1980 and 2018 [1]. Across studies examining asthma, COPD, chronic bronchitis, and bronchiectasis, the authors identified consistent improvements in spirometric measures: forced expiratory volume in one second (FEV1), forced vital capacity (FVC), and peak expiratory flow (PEF). Quality-of-life scores improved alongside objective lung function in most studies. The review noted that while the evidence is encouraging, halotherapy lacks standardized clinical protocols and official treatment guidelines, and the authors called for large, rigorously designed randomized controlled trials to establish dosing parameters.

Comprehensive Asthma Review (Crisan-Dabija et al., 2021)

This 2021 review in Healthcare (Basel) analyzed 18 original studies examining halotherapy specifically in asthma, covering diagnostic use of hypertonic saline bronchial challenges, therapeutic effects, and prevention [2]. The diagnostic applications — using saline inhalation to provoke bronchial hyper-responsiveness for asthma diagnosis — are well established and distinct from the therapeutic use. On the therapeutic side, the review found that participants exposed to dry salt aerosol showed reductions in bronchial hyper-responsiveness and exhaled nitric oxide, with improved pediatric asthma quality-of-life scores (miniPAQLQ). The authors noted the absence of documented adverse effects across the reviewed literature and concluded halotherapy represents a viable complementary strategy alongside standard pharmacological management. As with most halotherapy research, the authors flagged the need for larger, more rigorous trials.

Pediatric RCT (Bar-Yoseph et al., 2017)

This randomized controlled pilot study in Pediatric Pulmonology is one of the most methodologically rigorous trials in halotherapy research [3]. Fifty-five children with mild asthma were assigned to either an active salt room (with halogenerator running) or an identical-appearing sham room (no salt generation). Over 7 weeks, the active treatment group showed statistically significant improvement in bronchial hyper-responsiveness (measured by PC20, the methacholine concentration producing a 20% drop in FEV1), while the sham group showed no change. Notably, there was no improvement in spirometry (FEV1 or FVC) or fractional exhaled nitric oxide (FeNO) levels in the treatment group. Quality of life, measured by the miniPAQLQ, did improve significantly. The authors concluded the therapy "may have some beneficial effects" in mild asthmatic children but appropriately qualified that the pilot design and short follow-up period limit firm conclusions. The study is important for being double-blind with a sham control — a design standard that many earlier halotherapy studies did not meet.

COPD Systematic Review (Rashleigh et al., 2014)

This review from International Journal of Chronic Obstructive Pulmonary Disease specifically examined the halotherapy evidence base for COPD and delivered a notably cautious verdict [4]. Despite an initial search identifying 151 potentially relevant studies, only one randomized controlled trial met strict inclusion criteria; three additional case-control studies were included to broaden analysis. The pooled data encompassed 1,041 participants across four studies, with outcomes grouped into respiratory function, quality of life, and medication use. Methodological limitations were pervasive: inadequate randomization, lack of blinding, and selection bias were common. The authors concluded that "recommendations for inclusion of halotherapy as a therapy for COPD cannot be made at this point" and that well-designed trials are needed before clinical adoption. This review is an important counterweight to more optimistic summaries and illustrates that evidence quality varies significantly across respiratory conditions.

Salt Therapy for Mold-Related Respiratory Illness (Wasik & Tuuminen, 2021)

This paper in Alternative Therapies in Health and Medicine examined a specific and underexplored application: salt therapy for patients with respiratory problems related to indoor dampness and mold exposure [5]. The authors reviewed the mechanisms by which inhaled NaCl aerosol — both speleotherapy (natural salt cave) and halogenerator-based halotherapy — reduces bacterial burden, modulates inflammation, reduces IgE, and facilitates mucociliary transport. They noted that for patients whose respiratory symptoms are driven by mold-related sensitization and microbial byproducts, the antibacterial and anti-inflammatory properties of salt therapy may address multiple pathological mechanisms simultaneously. The authors characterized the treatment as "safe and well tolerated" and positioned it as a complementary intervention alongside standard avoidance of damp environments. While the paper is partly mechanistic review rather than clinical trial, it provides useful context for understanding why salt therapy appears beneficial across different underlying causes of respiratory inflammation.

References

Halotherapy for Chronic Respiratory Disorders: From the Cave to the ClinicalBarber D, Malyshev Y, Oluyadi F, Andreev A, Sahni S. Alternative Therapies in Health and Medicine, 2022. PubMed 32827399 →
Halotherapy-An Ancient Natural Ally in the Management of Asthma: A Comprehensive ReviewCrisan-Dabija R, Sandu IG, Popa IV, Scripcariu DV, Covic A, Burlacu A. Healthcare (Basel), 2021. PubMed 34828649 →
Halotherapy as asthma treatment in children: A randomized, controlled, prospective pilot studyBar-Yoseph R, Kugelman N, Livnat G, Gur M, Hakim F, Nir V, Bentur L. Pediatric Pulmonology, 2017. PubMed 27723955 →
A review of halotherapy for chronic obstructive pulmonary diseaseRashleigh R, Smith SMS, Roberts NJ. International Journal of Chronic Obstructive Pulmonary Disease, 2014. PubMed 24591823 →
Salt Therapy as a Complementary Method for the Treatment of Respiratory Tract Diseases, With a Focus on Mold-Related IllnessWasik AA, Tuuminen T. Alternative Therapies in Health and Medicine, 2021. PubMed 34726628 →